Standard & Poor's Reports March Index Returns April 2, 2007

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Mereo Biopharma Group Plc	LSE:MPH	London	Ordinary Share	GB00BZ4G2K23	ORD GBP0.003 (REG S)

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	0.00	0.00%	26.50	26.00	27.00				0.00	01:00:00

Industry Sector	Turnover	Profit	EPS - Basic	PE Ratio	Market Cap
	0	0		N/A	0

Mereo Biopharma (LSE:MPH)
Historical Stock Chart

From May 2019 to May 2024

Click Here for more Mereo Biopharma Charts.

NEW YORK, April 2 /PRNewswire-FirstCall/ -- Standard & Poor's Reports March Index Returns April 2, 2007 Dividend Reinvested Index 30-Mar- S&P US Indices Values 07 3 Months YTD S&P 500(1) 4760.422 1.118 0.640 0.640 S&P MidCap 400(2) 1601.492 1.346 5.798 5.798 S&P SmallCap 600(3) 557.271 1.677 3.207 3.207 S&P 900(4) 3925.434 1.138 1.054 1.054 S&P 1000 (4) 5575.367 1.457 4.912 4.912 S&P Composite 1500(4) 394.214 1.159 1.140 1.140 S&P 100(5) 1005.653 1.063 -1.058 -1.058 S&P REIT Composite(6) 387.817 -2.244 3.705 3.705 S&P 500 Equal Weighted(7) 2738.33 0.79 2.83 2.83 S&P 500/Citigroup Value*(8) 2775.824 1.300 1.338 1.338 S&P 500/Citigroup Growth*(8) 1347.816 0.926 -0.094 -0.094 S&P MidCap 400/Citigroup Value*(8) 934.450 1.048 5.674 5.674 S&P MidCap 400/Citigroup Growth*(8) 718.840 1.648 5.927 5.927 S&P SmallCap 600/Citigroup Value*(8) 549.420 1.037 2.170 2.170 S&P SmallCap 600/Citigroup Growth*(8) 355.359 2.364 4.327 4.327 S&P US Indices 12 Months 3 Years 5 Years 10 Years S&P 500(1) 11.830 10.067 6.257 8.202 S&P MidCap 400(2) 8.445 13.367 10.681 14.282 S&P SmallCap 600(3) 5.293 13.903 11.670 12.563 S&P 900(4) 11.524 10.355 6.631 8.634 S&P 1000(4) 7.371 13.519 10.985 13.846 S&P Composite 1500(4) 11.256 10.498 6.820 8.754 S&P 100(5) 13.054 7.896 4.437 7.590 S&P REIT Composite(6) 22.063 22.445 21.884 14.526 S&P 500 Equal Weighted(7) 12.08 13.17 10.67 11.72 S&P 500/Citigroup Value*(8) 15.628 13.206 9.046 9.228 S&P 500/Citigroup Growth*(8) 8.077 6.972 3.444 6.743 S&P MidCap 400/Citigroup Value*(8) 11.048 15.037 12.960 na S&P MidCap 400/Citigroup Growth*(8) 5.566 11.556 8.211 na S&P SmallCap 600/Citigroup Value*(8) 6.904 14.465 11.655 na S&P SmallCap 600/Citigroup Growth*(8) 3.578 13.290 11.490 na Dividend Reinvested Index 30-Mar- S&P Global Indices Values 07 3 Months YTD S&P Asia 50 (US$)(7) 3707.29 1.68 0.67 0.67 S&P Europe 350 (EURO)(7) 1938.63 2.71 2.75 2.75 S&P Europe 350 (US$)(7) 2329.82 3.83 4.15 4.15 S&P Global 100 (US$)(7) 1750.28 1.77 0.18 0.18 S&P Global 1200 (US$)(7) 1990.46 2.01 2.36 2.36 S&P Latin America 40 (US$)(8) 4612.76 6.56 4.95 4.95 S&P/TOPIX 150 (US$)(8) 1793.92 -1.20 3.32 3.32 S&P/TOPIX 150 (YEN)(8) 1633.91 -1.69 2.31 2.31 S&P Euro (Euro)(7) 2139.85 2.87 3.49 3.49 S&P Euro (US$)(7) 2606.15 4.00 4.90 4.90 S&P Euro Plus (EURO)(7) 2058.28 2.88 3.23 3.23 S&P Euro Plus (US$)(7) 2537.41 4.01 4.64 4.64 S&P United Kingdom (PDS)(7) 1706.45 3.12 2.70 2.70 S&P /TSX 60 (CN$)(9) 1492.22 1.39 1.81 1.81 S&P/ASX 50 35852.37 3.15 6.82 6.82 S&P ADR Index (USD) (TR)(7) 2223.42 2.54 2.55 2.55 S&P Japan 500 (YEN) (TR)(7) 1715.33 -1.62 2.41 2.41 S&P 700 (USD) (TR)(7) 2387.84 2.84 3.97 3.97 S&P/MIB Index (EUR) (TR) 52859.64 1.50 0.81 0.81 S&P/ASX 200 (AUD) (TR) 37103.54 3.29 6.89 6.89 S&P/TSX Composite Index (TR) 32025.58 1.17 2.60 2.60 S&P Global Indices 12 Months 3 Years 5 Years 10 Years S&P Asia 50 (US$)(7) 20.96 20.92 17.41 -- S&P Europe 350 (EURO)(7) 14.11 19.08 6.64 12.90 S&P Europe 350 (US$)(7) 25.96 22.46 16.21 11.01 S&P Global 100 (US$)(7) 15.31 11.55 7.58 8.38 S&P Global 1200 (US$)(7) 16.46 15.24 11.00 9.29 S&P Latin America 40 (US$)(8) 29.71 44.79 30.35 18.74 S&P/TOPIX 150 (US$)(8) 3.97 11.82 13.44 4.97 S&P/TOPIX 150 (YEN)(8) 4.30 16.48 10.82 4.62 S&P Euro (Euro)(7) 15.54 20.89 7.24 10.40 S&P Euro (US$)(7) 27.54 24.32 16.86 11.94 S&P Euro Plus (EURO)(7) 14.95 20.75 7.49 10.18 S&P Euro Plus (US$)(7) 26.89 24.18 17.13 11.85 S&P United Kingdom (PDS)(7) 9.60 16.83 7.38 7.65 S&P /TSX 60 (CN$)(9) 12.38 18.75 13.18 10.95 S&P/ASX 50 20.46 24.62 15.38 13.89 S&P ADR Index (USD) (TR)(7) 18.70 19.85 14.92 -- S&P Japan 500 (YEN) (TR)(7) 2.46 16.11 11.71 -- S&P 700 (USD) (TR)(7) 21.03 21.12 16.86 10.30 S&P/MIB Index (EUR) (TR) 14.81 19.68 7.97 -- S&P/ASX 200 (AUD) (TR) 21.78 25.87 16.73 -- S&P/TSX Composite Index (TR) 11.42 17.70 13.10 10.35 Notes: Dividend Reinvested Index Inception Dates: (1)1970, (2)1981, (3)1984, (4)1994, (5)1988, (6)1997, (7)1989, (8)1995, (9)1987, (10)1991, (11)1993 *12 month, 3, 5 and 10 year returns are based on the blended S&P/Barra & S&P/Citigroup Indices. 3, 5 and 10 year total returns are compounded annually. Dividends Monthly % Chg. w/o Dividend Dividends S&P 500(1) 1.660 0.998 S&P MidCap 400(2) 0.891 1.238 S&P SmallCap 600(3) 0.404 1.575 S&P Composite 1500(4) 0.371 1.041 S&P 100(5) 0.686 0.955 S&P REIT Composite(6) 0.000 -2.594 S&P 500/Citigroup Value*(8) 1.370 1.157 S&P 500/Citigroup Growth*(8) 0.853 0.830 S&P MidCap 400/Citigroup Value*(8) 0.576 0.894 S&P MidCap 400/Citigroup Growth*(8) 0.281 1.586 S&P SmallCap 600/Citigroup Value*(8) 0.540 0.885 S&P SmallCap 600/Citigroup Growth*(8) 0.212 2.317 Reinvested Index Value Inception Index Date Value S&P 500(5) 1988 2200.120 S&P MidCap 400(10) 1991 1065.712 S&P SmallCap 600(11) 1993 463.213 For more information contact: Standard & Poor's Index Services at 212.438.2046 or Standard & Poor's, a division of The McGraw-Hill Companies (NYSE:MHP), is the world's foremost provider of independent credit ratings, indices, risk evaluation, investment research and data. With approximately 7,5000 employees located in 21 countries an Founded in 1888, The McGraw-Hill Companies is a leading global information services provider meeting worldwide needs in the financial services, education and business information markets through leading brands such as Standard & Poor's, BusinessWeek and M DATASOURCE: Standard & Poor's CONTACT: Paul Guarino of Standard & Poor's, Web site: http://www.standardandpoors.com/

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

MPH Mereo Biopharma Group Plc